The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Chronic Hepatitis B Management

HBV DNA monitoring, tenofovir, entecavir, hepatocellular carcinoma surveillance

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Internal Medicine department. Book Appointment →

What is Chronic Hepatitis B Management?

Hepatitis B virus is a hepatotropic DNA virus transmitted via blood, sexual contact, and perinatally. Chronic infection follows in 90 percent of perinatally infected infants, 30 percent of children aged 1 to 5, and under 5 percent of adults. Disease phases include immune-tolerant, immune-active, inactive carrier, and reactivation states.

Treatment indications include HBV DNA above 2,000 IU per milliliter with elevated ALT and significant liver inflammation or fibrosis on biopsy, or any HBV DNA detectable in cirrhosis. Active treatment uses tenofovir alafenamide, tenofovir disoproxil, or entecavir as first-line agents. Pegylated interferon alfa is alternative finite duration option.

Treatment goals are sustained HBV DNA suppression below 10 to 20 IU per milliliter, ALT normalization, HBeAg seroconversion in HBeAg-positive patients, and reduced cirrhosis and hepatocellular carcinoma progression. Therapy is typically lifelong. HCC surveillance with ultrasound and alpha-fetoprotein every 6 months in cirrhosis, family history, and elevated risk groups.

Symptoms

Often asymptomatic in chronic phase
Fatigue and right upper quadrant discomfort
Jaundice during reactivation
Spider angiomas and ascites in cirrhosis
Symptoms of hepatocellular carcinoma

Risk Factors

Mother with chronic hepatitis B
Endemic country birth
HIV or hepatitis C co-infection
Immunosuppression risk for reactivation
Family history of HBV or HCC

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • For positive HBsAg test screening
  • For elevated liver enzymes with HBV
  • For cirrhosis evaluation in chronic hepatitis B
  • For HCC surveillance every 6 months
  • Before immunosuppressive therapy initiation

Treatment Methods

01
Tenofovir alafenamide or entecavir first-line
02
Long-term oral antiviral with lifelong duration usually
03
HBV DNA monitoring every 3-6 months
04
ALT and creatinine monitoring on therapy
05
Pegylated interferon alpha alternative for select patients
06
HCC surveillance ultrasound and AFP every 6 months in high risk

Which Department to Visit?

You can visit our Enfeksiyon Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Enfeksiyon Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Flu (Influenza)

Enfeksiyon Hastalıkları

Influenza is a seasonal contagious respiratory disease caused by influenza viruses; it presents with high fever, muscle pain, and severe fatigue.

COVID-19

Enfeksiyon Hastalıkları

COVID-19 is a contagious disease caused by the SARS-CoV-2 coronavirus with a wide clinical spectrum ranging from asymptomatic to severe pneumonia.

Upper Respiratory Tract Infection

Enfeksiyon Hastalıkları

Upper respiratory tract infections are diseases that include common cold, pharyngitis, sinusitis, and laryngitis, often of viral origin and self-limited.

Urinary Tract Infection

Enfeksiyon Hastalıkları

Urinary tract infections are common bacterial infections most often caused by Escherichia coli, presenting with burning and frequent urination.

Hepatitis A (HAV)

Enfeksiyon Hastalıkları

Hepatitis A is an acute, self-limited liver infection transmitted via the fecal-oral route causing acute hepatitis without chronicity; supportive care suffices in most cases, while vaccination prevents outbreaks and post-exposure prophylaxis within 2 weeks is effective.

Hepatitis B

Enfeksiyon Hastalıkları

Hepatitis B is a contagious infection caused by HBV virus transmitted via blood, sexual intercourse, and mother-to-child, that can become chronic and progress to cirrhosis and liver cancer.

Hepatitis C

Enfeksiyon Hastalıkları

Hepatitis C is a liver disease caused by HCV virus transmitted mainly by blood; the rate of chronicity is high, but cure is possible with new antiviral drugs.

HIV/AIDS Information

Enfeksiyon Hastalıkları

HIV is a virus that targets the immune system; if untreated, it progresses to AIDS. With modern antiretroviral therapy, HIV-positive individuals can lead healthy, long lives.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.